AstraZeneca has announced it will tighten its 340B contract pharmacy restrictions for all covered entity types.
Major Drug Company Sues Louisiana Over 340B Contract Pharmacy Law
Views
Drug manufacturer AstraZeneca, one of the first companies to place restrictions on 340B discounts in the contract pharmacy setting, has [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.